@generoom@coregenomics @ambulanzen Hi James and Mike. I always liked twitter as you two and others posted things I find interesting. I stayed partly as I accepted the free speech argument. These days I see very little from people I find interesting and far more that's offensive. Not sure the solution
@HeartSomerville Thank you @HeartSomerville. All three of us successfully completed the race. It has been an emotional day thinking of James. So far we have raised over ยฃ1000 and we want to thank everyone that has supported us. James's parents were there throughout the race which was very special
We are hiring TWO core-funded group leaders!
Each position comes with a flexible start-up package:
๐ฉโ๐ฌ2 postdocs and a technician
๐งโ๐2 PhD students
๐ฌbudgets for our state-of-the-art core facilities.
Ready to join our community of exceptional researchers?
https://t.co/PVf235zauY
@GavinGiovannoni I just read the article you wrote. I certainly find what you say compelling. It would be amazing if healthcare could get to the place you describe and we certainly need politicians to help drive this
@lindhartsen@MicrosoftTeams Mine stopped working yesterday. I have tried installing updates. It tries to do a firmware update but can't do so maybe there is a common issue
Inivata just posted two job adverts. They are for a Bioinformatics Scientist and a Medical Science Liaison. If you know anyone that would be interested please could you forward this link: https://t.co/1bjXXzOweR
@isliquidbiopsy@Inivata If you are interested in watching a talk on a really exciting assay for MRD detection follow this link. Equally if you want a laugh, keep watching to the Q&A (the audio wasnt working and I had no idea what was going on ๐)
@DarrinMDisley @tomhfh I would be interested to see the correlation for just 0-100 deaths on the early graph. This is essentially all the later graph is based on. Isn't it likely you would only see the correlation when deaths are high enough (so the real risk is a correlation over the coming weeks?)